News for Ardelyx, Inc. (41X.F)

Published at

Mar 2, 2021 1:04 AM

by markets.businessinsider.com

mixed

mixed

Knight Therapeutics Announces Canadian Commercial Launch of IBSRELA™ - New Innovative Treatment for Irritable Bowel Syndrome with Constipation

MONTREAL, March 01, 2021 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD), (“Knight”) a pan-American (ex-USA) specialty pharmaceutical co...

ARDX 41X.F 41X.BE KHTRF GUD.TO 04K.F

Read more →
Published at

Feb 8, 2021 4:11 PM

by insidermonkey.com

mixed

mixed

10 Best Small-Cap Biotech Stocks Under $10 in 2021

In this article we will list the 10 best small-cap biotech stocks under $10 in 2021. Click to skip ahead and see the 5 Best Small-Cap Biotech Stocks Under...

RPRX ARDX APTO AGLE 41X.F 41X.BE LTIA.F BDSI BCRX APS.TO 4551.T BD5.F BD5.BE

Read more →
Published at

Jan 12, 2021 7:40 PM

by marketscreener.com

positive

positive

Ardelyx : Corporate Presentation January 2021

Passionately committed to improving the lives of patients by discovering, developing and commercializing first- in-class targeted therapies that advance patient care ... | January 12, 2021

ARDX 41X.F 41X.BE

Read more →